Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Embecta Corp. Market Cap
Based on ratings from 6 stock analysts, the Embecta Corp. stock price is expected to increase by 9.41% in 12 months. This is calculated by using the average 12-month stock price forecast for Embecta Corp.. The lowest target is $18.2 and the highest is $26. Please note analyst price targets are not guaranteed and could be missed completely.
EMBC is a stock in Healthcare which has been forecasted to be worth $21.05 as an average. On the higher end, the forecast price is $26 USD by Marie Thibault from BTIG and on the lower end EMBC is forecasted to be $18.2 by from .
These are the latest 20 analyst ratings of EMBC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Marie Thibault BTIG | Buy | $26 | Upgrade | Nov 27, 2024 |
| Cecilia Furlong Morgan Stanley | Underweight | $12 | Maintains | Jul 15, 2024 |
| Cecilia Furlong Morgan Stanley | Underweight | $13 | Maintains | May 10, 2024 |
| Cecilia Furlong Morgan Stanley | Underweight | $16 | Maintains | Nov 22, 2023 |
| Cecilia Furlong Morgan Stanley | Underweight | $15 | Maintains | Oct 18, 2023 |
| Cecilia Furlong Morgan Stanley | Underweight | $16 | Maintains | Aug 24, 2023 |
| Cecilia Furlong Morgan Stanley | Underweight | $19 | Maintains | Jul 18, 2023 |
| Cecilia Furlong Morgan Stanley | Underweight | $29 | Maintains | May 15, 2023 |
| Cecilia Furlong Morgan Stanley | Underweight | $28 | Downgrade | Jan 6, 2023 |
| Cecilia Furlong Morgan Stanley | Equal-Weight | $31 | Maintains | Dec 21, 2022 |
| Cecilia Furlong Morgan Stanley | Equal-Weight | $33 | Maintains | Oct 11, 2022 |
| Marie Thibault BTIG | Neutral | Initiates | Sep 8, 2022 | |
| Cecilia Furlong Morgan Stanley | Equal-Weight | $36 | Maintains | Aug 16, 2022 |
Morgan Stanley | Equal-Weight | Initiates | Aug 1, 2022 | |
B of A Securities | Underperform | Initiates | Jun 21, 2022 |
When did it IPO
2022
Staff Count
2,200
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Mr. Devdatt Kurdikar
Market Cap
$1.11B
In 2023, EMBC generated $1.12B in revenue, which was a decrease of -0.77% from the previous year. This can be seen as a signal that EMBC's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 04 Dec 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - Embecta Corp. reported strong Q4 net income and EPS growth, leading to a share price increase. The company plans to cut costs by $65 million, restructure operations, and focus on GLP-1 therapies.
Why It Matters - Embecta Corp.'s strong Q4 results and restructuring plan signal enhanced profitability and cost efficiency, boosting investor confidence and share price amid strategic focus on core growth areas.
Mon, 02 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - EMBC, TOST, MNDY, NTRS, and MANU were added to the Zacks Rank #1 (Strong Buy) List on December 2, 2024, indicating strong investment potential.
Why It Matters - Zacks Rank #1 indicates strong potential for stock price appreciation, signaling favorable conditions for EMBC, TOST, MNDY, NTRS, and MANU, attracting investor interest.
Mon, 02 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - EMBC, BLBD, and ENVA have been rated as Zacks Rank #1 (Strong Buy) value stocks as of December 2, 2024.
Why It Matters - EMBC, BLBD, and ENVA being ranked as Strong Buy indicates strong potential for growth and value, suggesting favorable investment opportunities in these stocks.
Mon, 02 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - CTBI and EMBC were both ranked as Zacks Rank #1 (Strong Buy) income stocks on December 2, 2024.
Why It Matters - CTBI and EMBC being ranked as Zacks Rank #1 (Strong Buy) indicates strong growth potential and positive sentiment, likely attracting investor interest and driving stock prices higher.
Tue, 26 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Embecta Corp. (NASDAQ: EMBC) will hold its Q4 2024 Earnings Conference Call on November 26, 2024, at 8:00 AM ET, featuring key executives including CEO Dev Kurdikar and CFO Jake Elguicze.
Why It Matters - Embecta's Q4 earnings call provides insights into financial performance, management strategies, and future outlook, influencing stock valuation and investor sentiment.
Tue, 26 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Embecta Corp. (Nasdaq: EMBC) announced a quarterly cash dividend of $0.15 per share, payable on December 18, 2024, to stockholders of record by December 6, 2024.
Why It Matters - Embecta Corp's declaration of a quarterly dividend signals strong cash flow and profitability, enhancing shareholder value and potentially attracting income-focused investors.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
